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Key findings 
 
1. The aim of this Rapid Evidence Assessment (REA) was to determine the 
nature and extent of the international research evidence on current 
responses to end of life care for people with substance problems published 
between 2004-2016. 
2. There is a dearth of evidence overall and no body of evidence that 
identifies effective interventions, responses, or models of practice. 
3. This REA, therefore, refocussed on a broader scoping of the evidence and 
producing a systematic map of the evidence available, the themes and 
implications for practice, and future research. The same date parameters 
were set. 
4. A final sample of 60 papers was included in the review, 32 of which 
reported empirical research.  
5. Of the 32 empirical papers, quality assessment indicated that only nine 
were of high quality, 18 were of moderate quality and five were of low 
quality. 
6. Most of the papers reported on studies in North America and to a lesser 
extent, Europe and Australia. Only nine were UK based. 
7. Methodologically, quantitative studies dominated the available evidence. 
Only 11 papers (34.3%) were qualitative. 
8. The majority of papers focussed on some aspect of pain management and 
prescribing practice where there are, or have been, substance problems. 
Most of these focussed on people with cancer diagnoses. 
9. A small body of work focussed on particular groups of people, primarily 
homeless people, people with mental ill health and people with HIV. 
10. Six papers focussed on alcohol use among people with cancer diagnoses. 
11. There were some common recommendations relating to safe and effective 
pain management strategies, harm reduction strategies and the 
acknowledgement of complex comorbidities among this group of people. 
12. The literature highlighted the under-utilisation of preventative or primary 
care services by this group of people, the need for empathetic 
communication by professionals, and a flexible service response. 
 
This Briefing is drawn from a more detailed report (Witham et al., 2018) that 
sets out the findings of the REA including a listing of the final papers reviewed. 
The full report provides a narrative on some of the recommendations and 
practice challenges that were embedded in the papers. These data can help to 
extend the debate on how best to ensure that the health inequalities faced by 
people with substance problems needing end of life care are addressed. 
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Background 
In the last two decades there has been a number of changes evident among the 
population whose use of substances1 is problematic.  The most notable is the 
increase in the number of older drug users and a resultant rise in rates of death 
from non-drug related conditions (Beynon, 2010). This means that current and 
previous substance users now survive long enough to die of health conditions 
more commonly found in deprived cohorts of the wider population (Corkery 
2008; Beynon et al. 2010).  Further, changes in life expectancy in the general 
population leading to a pattern of population ageing is likely to be mirrored in 
the smaller population of substance users. The shifts in harm reduction and 
treatment policies means that older substance users (over the age of 40) are 
now more likely to die of a non-drug related cause than users under the age of 
40 (Stenbacka et al. 2008, Benyon et al. 2010).  
 
There has also been an increase in alcohol-related morbidity and mortality 
among older drinkers (Kaplan et al. 2012).  This increase runs parallel to the 
increasingly clear evidence that alcohol causes cancers of the oropharynx, 
larynx, oesophagus, liver, colon, rectum and breast (Connor 2016). Excessive 
alcohol consumption is linked to a number of other chronic and potentially end 
of life conditions, including cardiovascular disease and liver cirrhosis (Rehm et 
al 2009).  
 
Finally, the emergence and increasing use of New Psychoactive Substances 
(NPS - previously known as Legal Highs) is also part of the changing landscape 
of drug use. The impact of this increase on mortality and morbidity is not yet 
known. Some of the more immediate consequences of NPS use are apparent in 
the prisons system and in admissions to hospital accident and emergency 
departments for acute intoxication (Ralphs et al. 2017, Liakoni et al. 2016). 
 
For the general population, while life expectancy has been increasing, so too 
has the number of years spent at the end of life living with disability and ill-
health (Bell and Marmot 2017). This has led to a growth in the numbers of 
deaths which can be anticipated and which are likely to require palliative and 
end of life care (Etkind et al. 2017). However, little is known about the nature 
and extent of need for end of life care by substance using populations or how 
well services are equipped to work with the people with problematic substance 
use. The wider programme of research, of which this REA is part, set out to fill 
this gap in knowledge. Specifically, this REA focusses on determining what is 
already known as well as identifying gaps in the evidence base.  
 
                                                     
 
 
 
1 We use ‘substances’ to mean alcohol and other drugs. 
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Methodology 
This strand of the research programme exploring end of life care for people with 
substance problems set out to answer the following research question: 
 
What does the existing international research and wider literature 
tell us about current responses to end of life care for people with 
substance problems?  
 
The question focussed initially on care responses and was broken down further 
into the following objectives: 
 
1. explore and document the evidence base that already exists on responses 
to end of life care for people with substance problems,  
2. identify gaps in the evidence relating to focus and methodology,  
3. identify examples of good practice, and  
4. highlight future directions for research.  
 
The review was conducted with the rigour of planning and approach of an REA. 
However, as a result of the dearth of evidence and the diversity of the literature 
found in its early stages, it also encompassed a systematic mapping of the 
review’s findings. 
 
The following databases and search terms comprised the final search protocol 
(see tables 1 and 2 below). The search focussed on English language literature 
between the years 2004 to 20162. 
Table 1 – Search fields, databases and other sources 
 
Search within 
fields 
Keywords/ subject terms/abstract 
Databases Amed, Psycharticles, Ovid, Ageinfo, MedLine, 
Ebscohost, ASSIA, Social Care Online, Web of 
Knowledge (including Social Science Citations Index), 
Web of Science, SSCI, Samsha, NIAAA,  
Table 2 - Final search terms 
 
Key search 
terms: 
1. end of life, palliative, dying, death, life limiting, life 
threatening 
2. drug misuse/abuse/use, substance 
use/misuse/abuse, medication use or abuse, alcohol 
                                                     
 
 
 
2 2016 was the start date of the REA. 
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Inclusion and exclusion criteria were drawn up for each search and applied 
throughout the screening process; title, abstract, and full text. We also 
excluded tobacco-related studies. Excluded papers were coded A-E (see coding 
table below in table 3).  
Table 3 – Coding table 
 
A Is not related to palliative or end of life care. 
B Is not related to substance use. 
C  Is not related to palliative or end of life care nor substance use. 
D Not about pathways; not about professional practice concerns; 
not about family and social networks; not about impact or 
considerations. 
E Does not meet the above, but is of interest. 
 
For ‘borderline’ papers, further discussion took place between two reviewers as 
to whether the paper should be included in the review. If any disagreement 
remained, the papers were reviewed by a third member of the research team 
who had the casting vote.  
 
Assessing quality and relevance 
 
The quality of the individual studies was assessed based on six principles 
derived from DFID (2014) guidance; conceptual framing, transparency, 
appropriateness, cultural sensitivity, validity and cogency. The papers were 
scored on these six criteria using a three-point scale: 
  
▪ 3 = no concerns;  
▪ 2 = some minor concerns;  
▪ 1 = major concerns.  
This resulted in a score ranging from 6 to 18 for each study.  Nine studies were 
judged to be high quality, 18 moderate and 5 low. It is important to note that a 
low or moderate ‘quality’ rating does not imply that a study was poorly 
designed or executed, it can simply mean that the report of the study did not 
fully explain its design or methods. 
 
Findings 
The final search of peer reviewed articles resulted in 4384 hits. Application of 
the inclusion and exclusion criteria were applied at abstract and full text reading 
stages resulting in a final sample of 60 papers. The papers were extremely 
diverse in methodology, focus and audience. The systematic map below (figure 
1) illustrates the range of evidence found. 
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The majority of papers found were published in the last decade and were North 
American (USA or Canadian) in origin. Just over half were based on empirical 
research of some kind with more quantitative data than qualitative data 
presented.  The greater number of journal articles compared to other sources 
was a result of our search strategy which focussed on published research. 
 
As the systematic map shows (see figure 1 below), the evidence could be 
grouped around three main themes: pain management (n=25), homeless and 
marginalised populations (n=24) and alcohol-related papers (n=6). In addition, 
there were five remaining papers which were diverse in focus and methodology. 
There were some overlap of categories within the papers.  
 
The findings of this REA demonstrated a largely heterogeneous literature, with 
limited empirical work in any specific area of end of life care for people with 
substance problems. In the thematic analysis of these studies, pain 
management was, marginally, the largest category (n=25), followed by 
homeless and marginalised groups (n=24) and finally, alcohol-related papers 
(n=6). The majority of studies focused exclusively or predominantly on cancer 
populations, including 14 studies within the thematic category of pain 
management and all six of the papers related to the alcohol literature.  
 
Within the pain literature, six studies were from more general palliative care 
populations with three related to HIV and two to non-cancer chronic pain. There 
were a small number of miscellaneous papers (n=5). In terms of geographical 
distribution of the published literature, the majority of the studies were from 
North America, (n=46; 76.7%) with the second largest sample from Europe 
(n=11; 18.2%). Only nine papers were from the UK. Therefore, the majority of 
the published literature from this REA is from a narrow geographical area. 
Within the thematic category of homeless and marginalised populations, the 
studies focused on mental health needs, HIV and homelessness and often 
related to service provider response. This category was often represented by 
studies using qualitative approaches (n=9) and therefore exploratory in nature, 
examining both service user and service provider perspectives.    
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Figure 1 - Systematic Map: Substance Use and End of Life Care 
 
 
 
Date: (n = 60) 
(date parameters 2004-2016)
2004-2008 (n = 12) 20%
2009- 2012 (n = 23)  38.3%
2013-2016  (n = 25) 41.6%
Country (n = 60)
USA   (n = 34) 56.7% 
Canada (n = 12) 21.6%
UK   (n = 9)  13.3%
Australia   (n = 3)  5%
Italy  (n = 1)  1.6%
Sweden (n = 1) 1.6%
Type of Publication (n = 60)
Journal Article   (n = 58)  96.7%
Book chapter  (n = 2)  3.2%
Content (n = 60)
Pain management  (n = 25) 41.6%
Homelessness and marginalised 
groups  (n =24) 40%
Alcohol related  (n = 6)  10%
Other (n = 5) 8.3%
Empirical/ Unempirical (n = 60)
Empirical  (n = 32)  53.3%
Unempirical  (n = 28)  46.6%
Qualitative/ Quantitative/ Mixed 
Methods (n = 32)
Qualitative  (n = 11)  34.3%
Quantitative  (n = 21) 65.6% 
Mixed  (n = 0) 
Type of Study (n = 32)
EMPIRICAL
Cross sectional  (n = 6)  18.7%
Focus groups  (n = 2) 6.2 %
Interview  (n = 9)  28.1%
Survey (n =6) 18.7%
Retrospective Chart review (RCR) (n = 
9) 28.1%
Type of Study (cont.)
UNEMPIRICAL (n= 28)
•Case study  (n =10)  35.7%
•Description of practice  (n = 8)  28.5%
•Literature review  (n = 5) 17.8%
•Systematic review (n=3) 10.7%
•Book chapter (n=2) 7.1%
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Gaps in the evidence 
 
Key gaps in the evidence include: 
• Very little research has been done in the UK. Most published research in this 
area has been generated in North America.  
• Less than two thirds of the literature identified was empirical work with the 
remainder descriptive papers, book chapters, single case studies, or reviews 
of literature.  
• The existing evidence is also dominated by quantitative research with 
approximately one third of it using qualitative methods.  
• There were no identified papers related specifically to family or 
carers/supporters of people with substance problems at the end of life.  
• There were only eight papers that documented professionals’ perspectives, 
three that mentioned service user perspectives of family members and 
carers’ involvement, and seven that documented service users’ perspective 
or those with experience of receiving services previously. 
• Finally, the map shows a narrow and limited topic focus of the evidence to 
date3.  
• There were no intervention or evaluation studies and no practice models that 
were underpinned by a robust evidence base relating to substance use and 
end of life care.  
• There was no consensus about what constitutes good practice. 
• There were no studies relating to New Psychoactive Substance (NPS) use 
and its impact on end of life care.  
• There were only four papers examining older drug users (Beynon et al. 
2010a, 2010b, Roe et al.  2010 and Williams et al. 2014).  
 
Good practice recommendations 
A number of recommendations4 for practice emerged from the literature.  
 
Managing pain 
In terms of good practice in relation to pain management, most of the papers 
were based on anecdotal evidence rather than strong empirical data. There 
were, however, some common recommendations from the diverse papers 
focusing on risk management and risk assessment: 
                                                     
 
 
 
3 We offer a note of caution, however, in that the thematic groupings are our own and others may group them 
differently. 
4 These are recommendations highlighted in the research literature. 
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Not under prescribing for pain 
There was an acknowledgement in a number of papers that the most significant 
prescribing problem in relation to substance misuse is the persistent under 
treatment of pain in this population, driven by the inappropriate fear that 
opioids will be misused.  
 
Screening for substance use 
Identifying substance use was important for most authors with Arthur et al. 
(2016) suggesting that drug screening (within palliative care clinics) can be 
used to initiate an effective conversation about the potential dangers of drug 
behaviours. Most papers suggested universal screening using validated 
screening tools.  
 
Screening for risk factors for substance use 
Krashin et al. (2015) also suggested assessing for validated risk factors for 
developing problems with opioid use, for example, assessing for a history of 
substance use, including smoking, family history of substance misuse, history of 
childhood abuse including post-traumatic stress disorder, and psychiatric 
comorbidities (anxiety, depression, personality disorder).  
 
Talking about substance use 
Underpinning most papers was the prerequisite requirement of effective and 
often direct communication. Whether this happened, how to achieve it, and 
what sort of strategies would be helpful in managing direct conversations about 
substance misuse, was not a feature of the current literature. This literature 
also suggests that clinicians need to distinguish between pseudo-addictive 
behaviour(s), such as chemical coping and misuse of prescribed medication.  
 
Awareness of harm reduction approaches to substance use 
Underlying approaches to substance misuse were articulated by some authors, 
with harm reduction rather than abstinence seen as a more helpful approach 
and liaison with local substance misuse teams to reach realistic goals. 
 
Homelessness and marginalised groups 
The literature identified in this REA did not contain any papers which specifically 
identified recommendations. Some empirical papers proposed models which fell 
into the following four categories (see table 4 below): 
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Table 4: Guidelines for practice with homeless and marginalised people 
 
Category Practice guidelines 
Environment(s) of 
care 
Deliver services in settings familiar to service users 
(e.g. "shelter based care", services in needle 
exchanges). 
Philosophy of care Use of a harm reduction rather than abstinence 
only model. Services should aim for low threshold 
strategies, i.e. those with minimum restrictions on 
service users’ normal patterns of behaviour.  
Service delivery 
 
 
Need for services to be flexible and responsive. 
Need for coordinated care with a case 
manager/case worker to prevent service users 
slipping through the gaps. Partnering of agencies to 
promote joint working. 
Safety plans for 
identified high risk 
patients 
Piloting of supervised consumption (of both alcohol 
and illicit drugs). 
 
Alcohol literature 
The alcohol literature was sparse with only six papers included in this REA. The 
recommendations drawn from them are listed below in table 5: 
 
Table 5: Guidelines for practice with people with problematic alcohol use 
 
Category Practice guidelines 
Universal screening 
for alcohol misuse 
Universally screening for alcohol misuse using a 
validated tool (For example, CAGE).   
Ongoing screening 
and monitoring for 
alcohol use 
• Routine CAGE screening (younger patients 
are particularly at high risk of being CAGE 
positive).  
• Frequent pain assessment.  
• Assessment and treatment of alcohol 
withdrawal. 
Safety plans for 
identified patients 
with alcohol 
problems or high risk 
patients 
• Assess for mental disorders. 
• Involve and refer to specialist Multi-
disciplinary team support that may include 
psychiatric/ psychological, or drug 
rehabilitation services.  
• Frequent review of symptom distress. 
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Conclusion 
 
This Rapid Evidence Assessment set out to explore current responses to, and 
models of practice for, people living with problematic substance use and end of 
life care conditions. There is a dearth of research available on this topic and 
thus the focus of this review was broadened to identify what evidence was 
available, its focus, quality, and the gaps in the research evidence base.  
 
The resulting body of work comprised 60 papers, primarily from peer reviewed 
journals. It was disparate in focus, with a wide range of research populations, 
research questions and methodological choices. The available evidence resulted 
in three clear, but limited, groups of papers; those focussing on pain 
management and prescribing, alcohol and end of life care, and a small body of 
work on end of life care for marginalised groups including homeless people, 
people with mental ill health or HIV-related conditions.  
 
This is clearly an area of work where far more research is needed. The gaps 
identified are considerable and need to be filled in order to provide an evidence 
base on which to build future policy and good practice, both in the UK and 
internationally. 
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